This section of the website contains information that should be considered accurate as of the date presented. You acknowledge that this information may change over time and you should not assume that the information is accurate at a later date. Quest Diagnostics is not obligated to update the information contained in this section of the website.
Quest to acquire Mercy's outreach laboratory business serving providers and patients in Arkansas, Kansas, Missouri and Oklahoma
Quest Diagnostics (NYSE: DGX), the leading provider of diagnostic information services, and Mercy, one of the nation's most highly integrated, multi-state health care systems, today announced a...
-Quest will remain the exclusive, national clinical reference laboratory and testing provider for BlueCross BlueShield of Western New York and BlueShield of Northeastern New York members for all products-
SECAUCUS, N.J., March 2, 2021— BlueCross BlueShield of Western New York and BlueShield of Northeastern New York, two of New York’s leading insurance carriers, and Quest Diagnostics (NYSE:...
Collaboration empowers individuals to access professional medical advice, when and where they want it, for employer-sponsored laboratory and biometric screening
98point6, the on-demand digital primary care service that delivers personalized diagnosis, treatment and consultation to patients across the country, today announced a collaboration with Quest...
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today introduced a new COVID-19 testing service that aids in providing insight into an individual's...
--Daniel C. Stanzione to Retire from Board and as Lead Independent Director
Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced changes in the leadership of its Board of Directors. Daniel C. Stanzione,...
-- Quest Diagnostics to Provide Blood Specimen Collection for Galleri Through its Patient Service Centers and Mobile Phlebotomists --
MENLO PARK, Calif.-- GRAIL, Inc., a healthcare company whose mission is to detect cancer early, when it can be cured, today announced an agreement with Quest Diagnostics (NYSE: DGX), the leading...
Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at Citi's 2021 Healthcare Services, Medtech,...
- Quest will remain the preferred national clinical reference laboratory and testing provider for EmblemHealth and ConnectiCare members for all products
EmblemHealth, one of the nation's largest non-profit health insurers, and Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, have renewed their...
Quest Diagnostics has been named a Best Place to Work for LGBTQ Equality by scoring a perfect 100 on the Human Rights Campaign Foundation’s 2021 Corporate Equality Index (CEI) for the fifth...
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, will host a virtual Investor Day for institutional investors and financial analysts on Thursday,...
